Evidence map›Paper›PMID 19237526›Full record

ArticleInfection and immunity2009

T cells from lungs and livers of Francisella tularensis-immune mice control the growth of intracellular bacteria.

Carmen M Collazo, Anda I Meierovics, Roberto De Pascalis, Terry H Wu, C Rick Lyons, Karen L Elkins

Open access · greenAbstract read
In one paragraph

Article in Infection and immunity, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. mBio · 2026
    Article
  3. Article
  4. Frontiers in microbiology · 2023
    Article
  5. Article
  6. Article
  7. Article
  8. Deletion Mutants ofPathogens (Basel, Switzerland) · 2021
    Article
  9. Review
  10. Guanylate-Binding Proteins Are Critical for Effective Control ofFrontiers in cellular and infection microbiology · 2020
    Article
  11. Vaccine-Mediated Mechanisms Controlling Replication ofFrontiers in cellular and infection microbiology · 2018
    Article
  12. Adaptive Immunity toFrontiers in cellular and infection microbiology · 2018
    Review
  13. AnFrontiers in cellular and infection microbiology · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Carmen M CollazoLaboratory of Mycobacterial Diseases and Cellular Immunology, Division of Bacterial, Parasitic and Allergenic Products, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration, Rockville, Maryland 20852, USA.
Anda I Meierovics
Roberto De Pascalis
Terry H Wu
C Rick Lyons
Karen L Elkins
United States Food and Drug Administration · USUniversity of New Mexico · US

Funding

Pulmonary responses to Bioweapon Category A PathogensP01AI056295 · NIAID · UNIVERSITY OF NEW MEXICO · PI LOVCHIK, JULIE A · 2005 to 2009
$13.2M
Biology of Infectious Diseases &InflammationT32AI007538 · NIAID · UNIVERSITY OF NEW MEXICO HEALTH SCIS CTR · PI Michelle A Ozbun · 1998 to 2026
$5.2M
NIAID NIH HHS P01 AI056295NIAID NIH HHS T32 AI007538NIAID NIH HHS Y1-AI-6153-01/224-06-1322
6 · The paper itself

Abstract

Parenteral and respiratory vaccinations with the intracellular bacterium Francisella tularensis have been studied using the live vaccine strain (LVS) in a mouse model, and spleen cells from immune mice are often used for immunological studies. However, mechanisms of host immunological responses may be different in nonlymphoid organs that are important sites of infection, such as lung and liver. Using parenteral (intradermal) or respiratory (cloud aerosol) vaccination, here we examine the functions of resulting LVS-immune liver or lung cells, respectively. Surprisingly, LVS was considerably more virulent when administered by cloud aerosol than by intranasal instillation, suggesting method-dependent differences in initial localization and/or dissemination patterns. Only low doses were sublethal, and resolution of sublethal cloud aerosol infection was dependent on gamma interferon (IFN-gamma), tumor necrosis factor alpha, and inducible nitric oxide synthase. Nonetheless, survival of cloud aerosol or parenteral infection resulted in the development of a protective immune response against lethal LVS intraperitoneal or aerosol challenge, reflecting development of systemic secondary immunity in both cases. Such immunity was further detected by directly examining the functions of LVS-immune lung or liver lymphocytes in vitro. Lung lymphocytes primed by respiratory infection, as well as liver lymphocytes primed by parenteral infection, clearly controlled in vitro intracellular bacterial growth primarily via mechanisms that were not dependent on IFN-gamma activity. Thus, our results indicate functional similarities between immune T cells residing in spleens, livers, and lungs of LVS-immune mice.

Indexed as

AnimalsBacterial VaccinesColony Count, MicrobialFemaleFrancisella tularensisInterferon-gammaLiverLungMaleMiceMice, Inbred C57BLMice, KnockoutSpleenSurvival AnalysisT-LymphocytesTularemiaBacterial VaccinesInterferon-gamma

Identifiers

PMID19237526
PMCPMC2681748
OpenAlexW2134986478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.